Filing Details
- Accession Number:
- 0000899243-20-032831
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-07 07:00:23
- Reporting Period:
- 2020-12-03
- Accepted Time:
- 2020-12-07 07:00:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1571498 | Epizyme Inc. | EPZM | Pharmaceutical Preparations (2834) | 261349956 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1746830 | Shefali Agarwal | C/O Epizyme, Inc., 400 Technology Square Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 | Disposition | 2020-12-03 | 2,522 | $13.54 | 76,089 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted under the issuer's 2013 Stock Incentive Plan on December 2, 2019. The automatic sale of the reporting person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the reporting person.
Billionaire Hedge Funds
